
MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
LATEST POSTS
- 1
Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application - 2
World's oldest known tortoise still very much alive despite rumor to the contrary - 3
Journey Lines for Each Explorer: Track down Your Ideal Journey - 4
Step by step instructions to Keep up with Ideal Oral Cleanliness at Home - 5
The pinch at the pump continues on
Von der Leyen: Paris meeting sends signal of unity for Ukraine
Home Mechanization Frameworks for Brilliant Residing
Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
Mom warns of Christmas gift hazard as daughter recovers in hospital
Private sector revives the climate disaster database Trump tried to squash
Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day?
Who was Haytham Ali Tabatabai, Hezbollah's military leader killed by Israel?
Israel's fractured opposition hands Netanyahu a full term
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial












